# Tampostat for Management of Postpartum Hemorrhage

> **NCT02416089** · PHASE1,PHASE2 · TERMINATED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 344 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DEVICE:** Tampostat
- **DEVICE:** Condom catheter tamponade

## Key facts

- **NCT ID:** NCT02416089
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2018-11-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416089, "Tampostat for Management of Postpartum Hemorrhage". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02416089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
